DrMilosSimic (@DrMilosSimic) header
DrMilosSimic (@DrMilosSimic) profile picture

Synthetic immunologist building therapies for 🧠 diseases. Assistant Professor at UChicago. Postdoc at UCSF in Wendell Lim’s lab. PhD work with Andrew Dillin

Joined February 2019
Huge congratulations to Christian Cordano, Sasha Gupta, and Caroline Guglielmetti, and all co-authors across @UCSF, @WUSTL and @UChicago. Deep thanks to Wendell Lim, Ari Green, Scott Zamvil, Stephen Hauser, and Michael Wilson at UCSF. Cross-disciplinary science at its best. 🙏
45
The broader idea I’m most excited about: CAR T cells as programmable perturbative agents. Not just therapies, but tools for constructing defined pathology in vivo.
30
Then the test: clemastine, a remyelinating compound, reduced lesion size and improved optic nerve conduction while inflammation was still present. That’s the scenario remyelinating drugs actually face in patients. 🎯
34
The lesions come with the features you want in a model: demyelination, axonal injury, and slowed optic nerve conduction. Discrete optic nerve lesions resembling human MS, rather than the diffuse damage of classic EAE.
34
Our approach: human CD4+ T cells engineered with a CAR against myelin oligodendrocyte glycoprotein (MOG), transferred into immunodeficient mice. They infiltrate brain, spinal cord, and optic nerve and make discrete, reproducible demyelinating lesions.
52
Why has remyelination been so hard to drug? Partly because our models don’t reproduce the hard case: a lesion that stays inflamed, where remyelination fails. So we decided to build that lesion ourselves.
65
The problem: every MS therapy we have reduces inflammation. None restores myelin. And disability keeps accruing even without relapses.
110
A new grant from @Biohub will help @UChicagoPME Asst. Prof. @DrMilosSimic advance research aimed at detecting neurodegenerative diseases like Alzheimer’s and Parkinson’s decades before cognitive decline appears. 🔗 Read more: ms.spr.ly/6018vu52y #Biohub #UChicago #Alzheimers #Parkinsons
4
11
690
Thrilled and honored to share that the Simic Lab has been selected as one of 15 teams worldwide to receive a synthetic biology grant from Biohub! 🎉 Thank you! More here: biohub.org/blog/immune-cell-… and pme.uchicago.edu/news/biohub…
1
1
10
544
We’re happy to welcome @DrMilosSimic as a Neubauer Family Assistant Professor of Molecular Engineering at @UChicagoPME! Dr. Simic is a synthetic immunologist and his research focuses on combining cell engineering and synthetic biology to understand and treat brain diseases. Welcome to the University of Chicago Pritzker School of Molecular Engineering, Milos! Learn more: pme.uchicago.edu/news/engine…
1
1
8
706
🚨 New Preprint 🚨 A continuous landscape of signaling encodes a corresponding landscape of CAR T cell phenotype How can we tune JAK/STAT signaling to create better immune cell therapies? doi.org/10.1101/2025.06.05.6…
12
55
7
183
20,306
Why test #celltherapies one-by-one when you can use multiplexed #SynBio, #proteinengineering & #ML to design, measure & track them at scale? The Goodman Lab @PennMedicine opens July 2025. We’re hiring Specialists & Postdocs! Apply @ bit.ly/42BnJNJ RTs appreciated!🙏
9
46
6
177
20,711
DrMilosSimic retweeted
🚨Excited to share our latest work, now out in @NatureBiotech ! We introduce SEED-Selection, a powerful method that enables high-efficiency enrichment of T cells edited at multiple loci in a single step 🧵👇 🔗 nature.com/articles/s41587-0…
10
36
1
132
18,038
Ligand-restricted synNotch switches enable precision cell therapy dlvr.it/THcbMP #immunology
15
50
4,951
#ScienceSaturday Treating #neurological disorders like #brain tumors is difficult in part due to a protective “wall” called the blood-brain barrier, meant to block toxins from reaching brain cells. ➡️ In this study, @DrMilosSimic, @NishRReddy, Et al. developed brain-sensing T cells, engineered to deliver brain tumor-specific chimeric antigen receptors upon sensing the brain tumor microenvironment. ➡️ This approach could pave the way for safer and more effective treatments for diseases like brain tumors, brain metastases, neuro-inflammation and more. 🔗 Here's a link to the full article: science.org/doi/10.1126/scie…
1
16
1
30
3,919
DrMilosSimic retweeted
From suppressing unwanted immunity to inducing immunity where it counts, SynNotch-engineered T cell can carry diverse payloads to specific locations, allowing for customized effects in numerous treatments bit.ly/4gfNUh8 @DrMilosSimic @CDI_UCSF @parkerici @NishRReddy
2
12
1,148
Big news today: 2 papers and the cover of @ScienceMagazine! @NishRReddy et al. built T cells that suppress inflammation in specific tissues science.org/doi/10.1126/scie… @DrMilosSimic, Payal Watchmaker et al. built T cells that deliver therapies to the brain science.org/doi/10.1126/scie…
1
6
1
11
1,751